INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 228 filers reported holding INSMED INC in Q1 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,572,672 | +19.3% | 101,888 | -0.3% | 0.00% | 0.0% |
Q2 2023 | $2,155,998 | +21.7% | 102,180 | -1.7% | 0.00% | – |
Q1 2023 | $1,772,109 | -5.6% | 103,936 | +10.7% | 0.00% | -100.0% |
Q4 2022 | $1,876,542 | +18.5% | 93,921 | +27.8% | 0.00% | 0.0% |
Q3 2022 | $1,583,000 | +19.2% | 73,483 | +9.1% | 0.00% | – |
Q2 2022 | $1,328,000 | -14.3% | 67,336 | +2.2% | 0.00% | – |
Q1 2022 | $1,549,000 | -5.7% | 65,910 | +9.3% | 0.00% | – |
Q4 2021 | $1,643,000 | -3.4% | 60,304 | -2.3% | 0.00% | – |
Q3 2021 | $1,700,000 | -90.5% | 61,749 | -90.2% | 0.00% | -100.0% |
Q2 2021 | $17,919,000 | -55.6% | 629,615 | -46.8% | 0.00% | -63.6% |
Q1 2021 | $40,332,000 | +79.1% | 1,184,122 | +75.0% | 0.01% | +57.1% |
Q4 2020 | $22,521,000 | +169.6% | 676,513 | +160.3% | 0.01% | +133.3% |
Q3 2020 | $8,353,000 | +749.7% | 259,893 | +628.5% | 0.00% | – |
Q2 2020 | $983,000 | +368.1% | 35,673 | +172.0% | 0.00% | – |
Q1 2020 | $210,000 | -36.9% | 13,116 | -6.0% | 0.00% | – |
Q4 2019 | $333,000 | +27.1% | 13,955 | -6.1% | 0.00% | – |
Q3 2019 | $262,000 | -33.7% | 14,863 | -3.7% | 0.00% | – |
Q2 2019 | $395,000 | -72.1% | 15,439 | -68.3% | 0.00% | – |
Q1 2019 | $1,414,000 | +311.0% | 48,654 | +186.3% | 0.00% | – |
Q3 2018 | $344,000 | -88.9% | 16,993 | -87.7% | 0.00% | -100.0% |
Q1 2018 | $3,103,000 | -24.8% | 137,785 | +4.1% | 0.00% | 0.0% |
Q4 2017 | $4,125,000 | +497.8% | 132,301 | +498.2% | 0.00% | – |
Q3 2017 | $690,000 | +91.7% | 22,118 | +5.3% | 0.00% | – |
Q2 2017 | $360,000 | -95.7% | 20,998 | -95.7% | 0.00% | -100.0% |
Q1 2017 | $8,467,000 | +39.8% | 483,554 | +5.7% | 0.00% | +50.0% |
Q4 2016 | $6,055,000 | -15.6% | 457,652 | -19.1% | 0.00% | -33.3% |
Q1 2016 | $7,172,000 | +143340.0% | 566,028 | +251468.0% | 0.00% | – |
Q2 2015 | $5,000 | -99.9% | 225 | -99.9% | 0.00% | -100.0% |
Q3 2014 | $4,936,000 | -36.0% | 378,251 | -2.1% | 0.00% | -33.3% |
Q2 2014 | $7,718,000 | +6.6% | 386,329 | +1.6% | 0.00% | 0.0% |
Q1 2014 | $7,241,000 | -17.5% | 380,280 | -26.4% | 0.00% | 0.0% |
Q4 2013 | $8,779,000 | +13.0% | 516,418 | +3.7% | 0.00% | 0.0% |
Q3 2013 | $7,772,000 | +4526.2% | 497,900 | +3437.0% | 0.00% | – |
Q2 2013 | $168,000 | – | 14,077 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |